Takeda Pharmaceutical Company Limited is a publicly traded company trading on NYSE, led by CEO Christophe Weber.
Upcoming earnings announcement for Takeda Pharmaceutical Company Limited
Past 12 earnings reports for Takeda Pharmaceutical Company Limited
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Jan 29, 2026 | Q3 2025 | $0.48Est: $0.55 | -13.6% | $7.6BEst: $8.5B | -10.9% | — |
| Oct 30, 2025 | Q2 2025 | $0.43Est: $0.44 | -2.3% | $7.5BEst: $8.1B | -6.9% | — |
| Jul 30, 2025 | Q1 2025 | $0.52Est: $0.47 | +11.1% | $7.7BEst: $7.5B | +1.7% | — |
| May 8, 2025 | Q4 2024 | $0.16 | — | $7.0B | — | — |
| Jan 30, 2025 | Q3 2024 | $0.44 | — | $7.5B | — | — |
| Oct 31, 2024 | Q2 2024 | $0.45Est: $0.57 | -21.1% | $7.9B | — | — |
| Jul 31, 2024 | Q1 2024 | $0.56 | — | $7.8B | — | — |
| May 9, 2024 | Q4 2023 | $0.24 | — | $7.1B | — | — |
| Feb 1, 2024 | Q3 2023 | $0.51 | — | $7.9B | — | — |
| Oct 26, 2023 | Q2 2023 | $0.48 | — | $6.3B | — | — |
| Jul 27, 2023 | Q1 2023 | $0.52 | — | $7.3B | — | — |
| May 11, 2023 | Q4 2022 | $0.39 | — | $7.2B | — | — |
We use cookies for analytics. See our Privacy and Cookie Policy.